Zohar Gendler

Biography

 Former CEO and director of Beta-O2 Technologies (a biomedical company which developed proprietary Implantable bio-artificial pancreas) for a period of 8 years, brought the company to one of the world leaders positioning in the area. Served as CEO of the Technion Entrepreneurial Incubator (TEIC) for a period of 11 years. Led the establishment and investment in more than 40 companies, such as Prolor Biotech (sold to Opko, NYSE: OPK, for $480M on August 2014), Mazor Robotics (NASDAQ: MZOR, TASE: MZOR.TA, www.mazorrobotics.com), ReWalk (NASDAQ: RWLK, www.rewalk.com), Corindus (NASDAQ: CVRS, www.corindus.com), Regentis (www.regentis.co.il) and many others. Gained a wide range of experience in identifying new technologies and in establishing, directing, and creating value for technology-based start-up companies. Served as a member of the Technion’s Patent Committee. (1998 – 2006). Earned his M.Sc. in material engineering, a B.Sc. in physics, and a certificate in business management, all from the Technion, Israel Institute of Technology.

Research Interest

 Dental, Dental implants, Dentistry